Replies to post #114 on GTC Biotherapeutics (fka GTCB)

[croumagnon]

"there is a 37.672% chance that they are worried...why???"

That, I believe is totally out of the question. I do not believe GTCB is worried in the least about getting the EU marketing authorization. If they were, then so would Harris and the rest that financed them and the deal would not have gone through.

I am convinced the EU marketing authorization is no more than a "rubber stamp" but I also think that GTCB felt that there is a chance their stock will stay in the doldrums until they start selling in the EU, which according to their latest guidelines is 2Q 07 I believe. This is cutting it close since their available cash up till this financing would only carry them to about that date. So, the bean counters probably convinced management that the time to finance is now so that after the EU gives them the authorization there will be no drag on the stock for a while to come.

I am unhappy about the financing because it gives these purchasers too much control and the ability to manipulate the stock. However, once these couple of after-shock days pass, I expect the stock to recover nicely back to the $1.4-$1.5 range and then get a boost further on the announcement of the EU marketing authorization. My only fear currently, in spite of Dew's assertions to the contrary, is that a low-ball private takeover could occur. However, even that would probably be at no less than $2 per share.